Physician profile
Larry E Burnett
NPI 1891750063
$1,517.06
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2020: $64.19 · 2021: $401 · 2022: $371 · 2023: $121 · 2024: $49.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $170.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $433.05 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $240.56 | 2019-2022 | |
| Amgen INC. | $124.57 | 2019-2023 | Repatha, Otezla |
| Abbvie INC. | $107.53 | 2021-2023 | Ubrelvy |
| Glaxosmithkline, LLC. | $76.70 | 2021-2023 | Bexsero, Shingrix, Rotarix |
| Merck Sharp & Dohme LLC | $69.93 | 2019-2023 | Steglatro, Belsomra |
| Astrazeneca Pharmaceuticals Lp | $61.65 | 2019-2022 | |
| Abbott Laboratories | $50.62 | 2021 | |
| Novartis Pharmaceuticals Corporation | $44.73 | 2019-2024 | |
| Astellas Pharma US INC | $34.94 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $29.15 | 2021-2022 | |
| Corium, LLC | $27.78 | 2022-2023 | Adlarity |
| Janssen Pharmaceuticals, INC | $27.28 | 2019 | |
| Sanofi-Aventis U.S. LLC | $24.76 | 2019-2020 | |
| Lilly USA, LLC | $24.36 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $21.64 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $19.82 | 2022 | |
| Ironshore Pharmaceuticals INC. | $15.47 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $15.19 | 2019 | |
| Boston Scientific Corporation | $15.15 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.29 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $13.58 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.71 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Burnett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.